SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-023683
Filing Date
2023-04-06
Accepted
2023-04-06 20:36:30
Documents
1
Period of Report
2023-04-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 20666
  Complete submission text file 0001209191-23-023683.txt   22081
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Issuer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877
Business Address
D'Angio Paul (Reporting) CIK: 0001843748 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40045 | Film No.: 23807574